Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
05/2008
05/13/2008US7371749 Benzothiazole derivatives
05/13/2008US7371748 Benzothiazole derivatives
05/13/2008US7371743 Carboxylic acid amides, the preparation thereof and their use as medicaments
05/13/2008CA2235298C Isoxazole derivatives
05/08/2008WO2008053861A1 Novel compound having 1,4-benzoxazin-3-one skeleton
05/08/2008WO2008052907A1 Substituted 2-imidazoles as modulators of the trace amine associated receptors
05/08/2008WO2008052899A1 Ether derivatives dual modulators of the 5-ht2a and d3 receptors
05/08/2008WO2008052898A1 Indazole derivatives useful as l-cpt1 inhibitors
05/08/2008WO2008036379A3 Serine hydrolase inhibitors
05/08/2008WO2007146856A3 Substituted gamma lactams as therapeutic agents
05/08/2008US20080108818 Provides compounds in pure form incorporated into a medicament, which possesses a sufficiently robust character resistant to chemical degradation, and thereby imparts a long shelf life to the medicament; photo stability
05/08/2008US20080108811 Aromatic Amine Derivative and Organic Electroluminescent Device Using Same
05/08/2008US20080108668 compounds with biological activity against all sorts of plant diseases and insects at very low dosage, to control plant diseases like cucumber downy mildew, cucumber grey mold, cucumber powdery mildew, tomato early blight, tomato late blight, phytophthora blight of pepper, grape downy mildew and etc
05/08/2008US20080108660 such as 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; antidepressant, anxiolytic agent, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability
05/08/2008US20080108653 Tripeptidyl peptidase inhibitors
05/08/2008US20080108634 Novel phenylalanine derivatives
05/08/2008US20080108629 Heterocyclic Derivatives for the Treatment of Diseases Mediated by Stearoyl-Coa Desaturase Enzymes
05/08/2008US20080108626 (5-amino-1-phenyl-1H-pyrazole)-(3-Amino-N-isoxazol-3-yl-4-methyl)-benzamide; p38 mitogen-activated protein kinase inhibitor; reduced levels of TNF- alpha expression; antiinfammatory agent: rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease
05/08/2008US20080108624 Methylene Dipiperidine Derivatives
05/08/2008US20080108620 N-(4-{(1S)-1-[3-(3,5-DICHLOROPHENYL)-5-QUINOLIN-3-YL-1H-PYRAZOL-1-YL]ETHYL}BENZOYL)- beta -ALANINE; glucagon receptor antagonists; antidiabetic agent; insulin resistance and its complications, including coronary heart disease, stroke, hypertension, nephropathy, neuropathy, retinopathy; atherosclerosis
05/08/2008US20080108619 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
05/08/2008US20080108616 as serine/threonine, fusion, and tyrosine kinase receptors as nerve and fibroblast growth factor; abnormal activation of immune and nervous systems; antiproliferative; lung; 4-(3-Trifluoromethyl-phenylamino)-pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-(4-morpholin-4-yl-phenylcarbamoyl)-phenyl]-amide
05/08/2008US20080108615 such as 4-(1-Hydroxyimino-indan-5-yl)-5-pyridin-4-yl-1H-imidazole-2-carboxylic acid (2-morpholin-4-yl-ethyl)-amide; anticarcinogenic agents, neurodegenerative diseases, brain disorders, stroke, antischemic agent
05/08/2008US20080108614 Substituted 2-Amino-Quinazolin-4-Cn Compounds for Use in the Treatment of Cns Disorders, Pain, Stroke, Addiction and Epilepsy, their Preparation and Use as Intermediates
05/08/2008US20080108611 Substituted thienopyrimidine kinase inhibitors
05/08/2008US20080108610 (4-Chloro-2-{[4-(2,4-diamino-pyrimidin-5-ylmethyl)-6,7-dimethoxy-benzofuran-2-ylmethyl]-amino}-phenyl)-pyrrolidin-1-yl-methanone; dihydrofolate reductase; bactericide; grampositive (Staphylococcus aureusand, Enterococcus faecalis) and and gramnegative pathogens (Escherichia coli, Haemophilus influenzae)
05/08/2008US20080108609 Benzoxazole Carboxamides For Treating CINV and IBS-D
05/08/2008US20080108608 Pyrimidines With Tie2 (Tek) Activity
05/08/2008US20080108601 anticancer agents; catalytic hydrogenation
05/08/2008US20080108596 Antiserotonine agents; psycholgical disorders; headaches; kits
05/08/2008US20080108595 Inhibitors of cathepsin s
05/08/2008US20080108591 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy
05/08/2008US20080107608 selective modulators of corticotropin -releasing factor (CRF) receptors, central and periphereal nervous system disorders; antidepressant, anxiolytic agent; stress, cardiovascular disorders, and eating disorders; probes for the localization of CRF receptors
05/08/2008US20080105865 Pyrene Based Compound and Light Emitting Transistor Element Using the Same
05/08/2008CA2668491A1 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation
05/08/2008CA2668454A1 Substituted 2-imidazoles
05/08/2008CA2668006A1 Substituted pyridin-3-yl amides as 1.beta.hsd1 inhibitors
05/08/2008CA2667685A1 Indazole derivatives useful as l-cpt1 inhibitors
05/08/2008CA2667511A1 Ether derivatives dual modulators of the 5-ht2a and d3 receptors
05/07/2008EP1918279A2 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and opioid receptor like receptor (ORL1) ligands for the treatment of pain
05/07/2008EP1917262A1 Piperidine and piperazine derivatives as p2x3 antagonists
05/07/2008EP1917261A1 Triazolyl derivatives of azabicyclo [3.1.0] hexane as dopamine d3 receptor modulators
05/07/2008EP1628971B1 TRIAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
05/07/2008EP1480951B1 Synthesis of indole thiazole compounds as ligands for the ah receptor
05/07/2008EP1405848B1 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient
05/07/2008EP1299381B1 Substituted quinazoline derivatives and their use as inhibitors
05/07/2008CN101175752A Polymorphic forms of (s)- tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate
05/07/2008CN101175750A Fungicide 2-pyridyl-methylene-carboxamide derivatives
05/07/2008CN101175747A Substituted N-arylpyrrolidines as selective androgen receptor modulators
05/07/2008CN101175736A Compound, composition, phase difference plate, elliptically polarizing plate and liquid crystal display device
05/07/2008CN101175726A Process for the preparation of opioid modulators
05/07/2008CN101175725A Process for the preparation of opioid modulators
05/07/2008CN101175722A Azetidine derivatives as ccr-3 receptor antagonists
05/07/2008CN101175718A Processes for preparing biaryl ureas and analogs thereof
05/07/2008CN101172983A Substituted phenylacetic acids
05/07/2008CN100386325C Novel oxazole derivatives, their manufacture and use as pharmaceutical agents
05/07/2008CN100386324C Compound of isobioquin group and application thereof
05/07/2008CN100386321C Y-type second-order non-linear optical luminophor contg. triphenylamine, prepn. method and use thereof
05/06/2008US7368585 Protected trihydroxyisoalkatrienyltriphenylphosphonium halides for proparing polyhydroxylactones; acid stable protecting groups include p-methoxybenzyl and tert-butyldimethylsilyl.
05/06/2008US7368568 Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for production and the use
05/06/2008US7368451 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects
05/06/2008US7368447 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects
05/06/2008US7368446 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
05/06/2008US7368445 Fused pyrazole derivatives as TGF-β signal transduction inhibitors for the treatment of fibrosis and neoplasms
05/06/2008US7368444 4-Hydroxy-1-toluenesulfonyl-2,3,4,5-tetrahydro-1H-1-benzazepine, for example; useful as the preventive and/or treatment medicine against diseases caused by stress
05/06/2008US7368224 Photopolymerizable composition
05/06/2008CA2430601C Piperazine derivatives
05/06/2008CA2280727C Bicyclic amino acids
05/06/2008CA2258949C Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
05/02/2008WO2008051942A2 Farnesoid x receptor agonists
05/02/2008WO2008051873A2 Phenylurea compounds as soluble epoxide hydrolase inhibitors
05/02/2008WO2008051547A1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and c-met inhibitors
05/02/2008WO2008050200A1 Oxadiazole compounds as calcium channel antagonists
05/02/2008WO2008049950A1 Novel polynitrogenated systems as anti-hiv agents
05/02/2008WO2008049875A1 Novel substituted piperidyl-propane-thiols
05/02/2008WO2008049864A1 Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators
05/02/2008WO2008049747A1 Novel heteroaryl carboxamides
05/02/2008WO2008049585A1 Pyridazine derivatives
05/02/2008WO2008011611A3 Compounds and compositions as itpkb inhibitors
05/02/2008WO2008006720A3 Crystalline nemorubicin hydrochloride
05/02/2008CA2669111A1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and c-met inhibitors
05/02/2008CA2667551A1 Novel polynitrogenated systems as anti-hiv agents
05/02/2008CA2667548A1 Substituted piperidyl-propane-thiols
05/02/2008CA2667545A1 Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators
05/02/2008CA2667435A1 Chemical compounds
05/02/2008CA2667235A1 Pyridazine derivatives
05/02/2008CA2666922A1 Novel heteroaryl carboxamides
05/02/2008CA2666482A1 Soluble epoxide hydrolase inhibitors
05/01/2008US20080103301 photochromic materials are provided that are essentially free of polymerizable unsaturated groups, and comprise: a) an indeno[2',3':3,4]naphtho[1,2-b]pyran; and b) an electron-withdrawing, non-conjugating group bonded at the 11-position of the indeno[2',3':3,4]naphtho[1,2-b]pyran
05/01/2008US20080103300 Preparation of quinoxaline compounds
05/01/2008US20080103182 N-[1-(4-Difluoromethoxy-benzyl)-1H-indazol-3-yl]-terephthalamic acid;liver carnitine palmitoyl transferase 1 (L-CPT1) nhibitor; antidiabetic and hypotensive agent; obesity, insulin resistance, hyperglycemia; reduce liver beta -oxidation, consequently inhibit gluconeogenesis
05/01/2008US20080103180 CCR9 inhibitors and methods of use thereof
05/01/2008US20080103148 Preventing ventilator induced pneumonia; utilizing compounds having longer half life on mucosal surfaces
05/01/2008US20080103143 3-{[(5-Chloro-thiophene-2-carbonyl)-amino]-methyl}-[1,2,4]oxadiazole-5-carboxylic acid [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide; blood coagulation factor Xa and thrombin inhibitor, anticoagulant; thrombotic disorders: thrombosis, angina pectoris, myocardial infarction, stroke, arteriosclerosis
05/01/2008US20080103142 c-Jun N-terminal kinase and cyclin-dependent kinase inhibitor; (4-benzotriazol-1-yl-5-chloro-pyrimidin-2-yl)-cyclohexyl-amine; antiinflammatory and anticarcinogenic agent; autoimmune and neurodegenerative disorders; rheumatoid arthritis, asthma, type II diabetes, Alzheimer's and Parkinson's diseases
05/01/2008US20080103141 tert-Butyl 4-[({5-[4-(hydroxymethyl)phenyl]pyrimidin-2-yl}oxy)methyl]piperidine-1-carboxylate; agonists of the G-protein-coupled receptor GPR119; antidiabetic, antiinflammatory agent, neuropathy, obesity; use with a dipeptidyl peptidase IV (DPP IV) inhibitor
05/01/2008US20080103140 Cyclohexylamides as Dopamine D3, D2 and 5Ht1a Antagonists
05/01/2008US20080103139 3-Carbamoyl-2-Pyridone Derivative
05/01/2008US20080103138 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
05/01/2008US20080103137 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases